Literature DB >> 26354799

Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.

Yoshiko Watanabe1, Tetsuro Miyata2, Kazuo Tanemoto2.   

Abstract

BACKGROUND: The clinical features of newly diagnosed Japanese patients with Takayasu arteritis and its age or sex specificities are unknown. METHODS AND
RESULTS: We analyzed information from nationwide registration forms submitted by patients with Takayasu arteritis between April 2001 and March 2011 as part of a research program by the Japanese Ministry of Health, Labor and Welfare. Among the 7779 patients who submitted their forms, 1372 newly registered patients with Takayasu arteritis were enrolled; 83.8% were female. The median age at onset was 35 years, which was significantly higher in male patients (median, 43.5 years) than in female patients (median, 34 years; P<0.001). Local symptoms and findings were most commonly observed in the cervicobrachial area, with more complaints in the head or neck than in the upper limbs. Approximately 85% of the patients had vascular involvements in the aortic arch or its major branches; many young female patients had localized lesions. Although male patients had extensive aortic lesions or aneurysms with more complications, localized abdominal lesions were relatively more frequent in male patients with age at onset >40 years than in other age-sex groups. Disease statuses were severe in patients who registered at ≥1 year after onset.
CONCLUSIONS: The proportions of male patients and patients with elderly onset increased in newly diagnosed patients with Takayasu arteritis. Their clinical and angiographic features differed according to onset age and sex.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Takayasu arteritis; epidemiology; peripheral vascular diseases; physiopathology; vasculitis

Mesh:

Year:  2015        PMID: 26354799     DOI: 10.1161/CIRCULATIONAHA.114.012547

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

Review 1.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

2.  Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Lingying Ma; Xiufang Kong; Huiyong Chen; Peng Lv; Jiang Lin; Hao Liu; Yan Yan; Zongfei Ji; Chengde Yang; Shengming Dai; Weiguo Wan; Yaohong Zou; Xuejuan Jin; Lindi Jiang
Journal:  Rheumatol Int       Date:  2017-10-13       Impact factor: 2.631

3.  Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Huiyong Chen; Xiufang Kong; Peng Lv; Xiaomin Dai; Zongfei Ji; Chengde Yang; Shengming Dai; Lijun Wu; Yaohong Zou; Jiang Lin; Hongcheng Shi; Qiang Yu; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-04-23       Impact factor: 2.980

4.  The role of CD8+ Granzyme B+ T cells in the pathogenesis of Takayasu's arteritis.

Authors:  Taotao Li; Na Gao; Wei Cui; Limin Zhao; Juan Du; Xuemei Shi; Junming Zhu; Zhiyu Qiao; Shichao Guo; Lili Pan
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 2.980

Review 5.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

6.  Clinical presentation, treatment and outcome of Takayasu's arteritis in southern Chinese: a multicenter retrospective study.

Authors:  Stella Pui Yan Wong; Chi Chiu Mok; Chak Sing Lau; Man Lung Yip; Lai Shan Tam; King Yee Ying; Woon Leung Ng; Kam Hung Ng; Moon Ho Leung; Tsz Yan Lee; Chi Hung To; Ka Lai Lee; Man Choi Wan; Ka Lung Yu; Priscilla Ching Han Wong; Chi Keung Sung; Kwok Fai Lee; Emily Wai Lin Kun
Journal:  Rheumatol Int       Date:  2018-09-04       Impact factor: 2.631

7.  Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension.

Authors:  Sun Ying; Wu Sifan; Wang Yujiao; Chen Rongyi; Huang Qingrong; Ma Lili; Chen Huiyong; Jiang Lindi
Journal:  Arthritis Res Ther       Date:  2021-07-21       Impact factor: 5.156

8.  Organizing Pneumonia as the First Presentation in a Patient with Takayasu Arteritis: A Report of Rare Complication.

Authors:  Yuki Shimada; Atsushi Shibata; Hirotoshi Ishikawa; Yumi Yamaguchi; Ryoko Kitada; Shoichi Ehara; Yasuhiro Izumiya; Minoru Yoshiyama
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

9.  Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review.

Authors:  Diana Prieto-Peña; Pilar Bernabeu; Paloma Vela; Javier Narváez; Jesús C Fernández-López; Mercedes Freire-González; Beatriz González-Álvarez; Roser Solans-Laqué; José L Callejas Rubio; Norberto Ortego; Carlos Fernández-Díaz; Esteban Rubio; Salvador García-Morillo; Mauricio Minguez; Cristina Fernández-Carballido; Eugenio de Miguel; Sheila Melchor; Eva Salgado; Beatriz Bravo; Susana Romero-Yuste; Juan Salvatierra; Cristina Hidalgo; Sara Manrique; Carlos Romero-Gómez; Patricia Moya; Noelia Álvarez-Rivas; Javier Mendizabal; Francisco Ortiz-Sanjuán; Iván Pérez de Pedro; José L Alonso-Valdivielso; Laura Perez-Sanchez; Rosa Roldán; Nagore Fernandez-Llanio; Ricardo Gómez de la Torre; Silvia Suarez; María Jesús Montesa Cabrera; Mónica Delgado Sánchez; Javier Loricera; Belén Atienza-Mateo; Santos Castañeda; Miguel A González-Gay; Ricardo Blanco
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-18       Impact factor: 5.346

Review 10.  Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.